161 related articles for article (PubMed ID: 21722089)
1. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism.
Lee KC; Shorr R; Rodriguez R; Maturo C; Boteju LW; Sheldon A
Drug Metab Lett; 2011 Aug; 5(3):163-82. PubMed ID: 21722089
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite.
Aprile S; Del Grosso E; Grosa G
Xenobiotica; 2009 Feb; 39(2):148-61. PubMed ID: 19255941
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the in vitro metabolites of idelalisib in liver microsomes and interspecies comparison.
Chen CM; Wu WB; Chen JF; Chen Y
J Pharm Biomed Anal; 2019 Jan; 162():249-256. PubMed ID: 30268993
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
6. Metabolite profiling of IMID-2, a novel anticancer molecule of piperazine derivative: In silico prediction, in vitro and in vivo metabolite characterization using UPLC-QTOF-MS/MS.
Panday NK; Thakkar D; Patel S; Shard A; Sengupta P
Biomed Chromatogr; 2021 Jun; 35(6):e5082. PubMed ID: 33570183
[TBL] [Abstract][Full Text] [Related]
7. Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS.
Rincon Nigro ME; Du T; Gao S; Kaur M; Xie H; Olaleye OA; Liang D
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566205
[TBL] [Abstract][Full Text] [Related]
8. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
[TBL] [Abstract][Full Text] [Related]
9. Identification of metabolites of meisoindigo in rat, pig and human liver microsomes by UFLC-MS/MS.
Huang M; Ho PC
Biochem Pharmacol; 2009 Apr; 77(8):1418-28. PubMed ID: 19426681
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes.
Chen M; Howe D; Leduc B; Kerr S; Williams DA
Xenobiotica; 2007 Sep; 37(9):954-71. PubMed ID: 17896323
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characterization of (±)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry.
Song YL; Jing WH; Yan R; Wang YT
J Pharm Biomed Anal; 2014 Mar; 90():98-110. PubMed ID: 24342524
[TBL] [Abstract][Full Text] [Related]
12. In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes.
Maul R; Warth B; Schebb NH; Krska R; Koch M; Sulyok M
Arch Toxicol; 2015 Jun; 89(6):949-60. PubMed ID: 24927789
[TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of deoxynivalenol (DON) by different animal species: identification of iso-DON glucuronides and iso-deepoxy-DON glucuronides as novel DON metabolites in pigs, rats, mice, and cows.
Schwartz-Zimmermann HE; Hametner C; Nagl V; Fiby I; Macheiner L; Winkler J; Dänicke S; Clark E; Pestka JJ; Berthiller F
Arch Toxicol; 2017 Dec; 91(12):3857-3872. PubMed ID: 28638985
[TBL] [Abstract][Full Text] [Related]
14. Applying human and pig hepatic in vitro experiments for sulfur mustard study: screening and identification of metabolites by liquid chromatography/tandem mass spectrometry.
Halme M; Pesonen M; Hakala U; Pasanen M; Vähäkangas K; Vanninen P
Rapid Commun Mass Spectrom; 2015 Jul; 29(14):1279-87. PubMed ID: 26405789
[TBL] [Abstract][Full Text] [Related]
15. Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
Liu Z; Floss HG; Cassady JM; Chan KK
J Mass Spectrom; 2005 Mar; 40(3):389-99. PubMed ID: 15674857
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.
Wen Z; Stern ST; Martin DE; Lee KH; Smith PC
Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of [
Nallani GC; ElNaggar SF; Shen L; Chandrasekaran A
Regul Toxicol Pharmacol; 2017 Mar; 84():26-34. PubMed ID: 27993653
[TBL] [Abstract][Full Text] [Related]
18. HT-2 toxin 4-glucuronide as new T-2 toxin metabolite: enzymatic synthesis, analysis, and species specific formation of T-2 and HT-2 toxin glucuronides by rat, mouse, pig, and human liver microsomes.
Welsch T; Humpf HU
J Agric Food Chem; 2012 Oct; 60(40):10170-8. PubMed ID: 22967261
[TBL] [Abstract][Full Text] [Related]
19. In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP-glucuronosyltransferase enzymes by ultra high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
Xu J; Li M; Yao Z; Zhang Y; Li S; Hu L; Qin Z; Gonzalez FJ; Yao X
J Pharm Biomed Anal; 2018 Sep; 158():351-360. PubMed ID: 29933228
[TBL] [Abstract][Full Text] [Related]
20. Species differences in bile acids II. Bile acid metabolism.
Thakare R; Alamoudi JA; Gautam N; Rodrigues AD; Alnouti Y
J Appl Toxicol; 2018 Oct; 38(10):1336-1352. PubMed ID: 29845631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
